InspireMD Receives Regulatory Approval for both CGuard™ EPS and MGuard Prime™ in Peru
Mar 27, 2018 11:00 am UTC| Business
Tel Aviv, Israel, March 27, 2018 -- InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that it has received...
Mar 27, 2018 11:00 am UTC| Business
DUBLIN, Ireland and HONG KONG, March 27, 2018 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious...
Unifi Software Available Through the Microsoft Azure Marketplace
Mar 27, 2018 11:00 am UTC| Business
SAN MATEO, Calif., March 27, 2018 -- Unifi Software, a leader in providing a seamlessly integrated suite of self-service data tools, today announced the Unifi Data Platform is now available through the Microsoft Azure...
Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2017
Mar 27, 2018 11:00 am UTC| Business
CHESTERFIELD, Mo., March 27, 2018 -- Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and...
Shipt and Target to Launch Same-Day Delivery Across New England
Mar 27, 2018 11:00 am UTC| Business
BIRMINGHAM, Ala. and MINNEAPOLIS, March 27, 2018 -- Shipt, a leading online marketplace, and Target Corporation (NYSE:TGT) today announced they will begin same-day delivery of more than 55,000 groceries, essentials,...
Antares Pharma Provides XYOSTED™ Regulatory Update
Mar 27, 2018 11:00 am UTC| Business
EWING, N.J., March 27, 2018 -- Antares Pharma, Inc. (NASDAQ:ATRS) (the Company) today announced that the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA or the Agency) held on...
Mar 27, 2018 11:00 am UTC| Business
NEW YORK, March 27, 2018 -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced...